How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Cambrex Corporation (CBM) reported second quarter 2003 earnings of $8.1 million or $0.31 diluted earnings per share (including a $0.01 diluted earnings per share benefit) versus $16.2 million or $0.61 diluted earnings per share in the second quarter 2002 (including an $0.08 diluted earnings per share benefit).
Worldwide sales for the second quarter 2003 improved 1.6% to $136.4 million from $134.3 million in the second quarter of 2002. The results reflect increased sales in Human Health, Rutherford Chemicals, and all other segments offset by lower sales in the biosciences segment. Gross profit for the quarter was $44.2 million (32.4% of sales) versus $53.0 million (39.5% of sales) in the second quarter 2002. Second quarter...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
